Developer docs
API playgroundTry for free, no card

Search company profiles

Nova IVF Fertility

Full company profile

uuid0005zbr

Namestring
Nova IVF Fertility
Legal namestring
Nova IVF Fertility (A unit of Rhea Healthcare Pvt Ltd)
Company typeenum
Private
Founded yearint
2006
Descriptiontext

Nova IVF Fertility operates one of India's largest assisted reproductive technology (ART) clinic networks, with 120 centers across 75 cities serving couples and individuals seeking fertility treatment, including patients from SAARC countries such as Bangladesh and Sri Lanka. The company's service portfolio spans the full fertility journey, from initial assessment through advanced procedures, including IUI, IVF, ICSI, PGT, vitrification, donor programs, fertility-preservation services, and specialised treatments such as Ovarian PRP and Lymphocyte Immunisation Therapy. Its core proprietary approach is Self-cycle™ IVF, which prioritises use of the couple's own gametes, supported by in-house developed clinical technology including an RFID-based electronic witnessing system that prevents sample mix-ups, time-lapse embryo monitoring, MACS and ZyMot sperm selection, PICSI, Embryo Glue, and Endometrial Receptivity Analysis.

The technology stack was extended in August 2025 with the launch of Vita Embryo, an AI-enabled computer-vision platform for embryo selection, designed to improve IVF success rates. Nova IVF generates revenue through per-cycle unit pricing on fertility procedures (IUI at ~₹7,500-9,000, IVF from ₹99,000-120,000, ICSI at ₹120,000-225,000, PGT at ₹80,000-150,000), with EMI financing offered to patients and a transparent pricing policy. The business is run as a unit of Rhea Healthcare Pvt Ltd, under Asia Healthcare Holdings, which is backed by global private equity firm TPG Capital; New Enterprise Associates was an early institutional investor in 2010. Nova IVF follows a direct-to-consumer go-to-market supported by a multi-channel digital presence (website, SEO, social media, WhatsApp, phone) and operates ancillary talent and training assets including the Nova Embryology Academy (NACET) and fellowship programs in Reproductive Medicine and Embryology.

Short descriptiontext

Nova IVF Fertility is an India-based fertility services chain operating 120 clinics across 75 cities, providing IVF, ICSI, IUI, PGT, and fertility preservation to couples and individuals, including SAARC international patients, under parent Asia Healthcare Holdings (TPG Capital).

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1,001–5,000
akta.pro rankint
HeadquartersBangalore, India
HQ citystring
Bangalore
HQ countrystring
India
HQ regionstring
Asia
Markets served

Serves global market

Offices30 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
IVF treatment, fertility services, assisted reproduction, fertility preservation, embryology services
Industry3 codes
PRIMARYHLAFAJAD
Fertility, Reproductive Endocrinology & IVF Centers
Healthcare & Life Sciences/Healthcare Providers & Systems/Women’s & Children’s Health Providers
SECONDARYHLAKAJAC
Reproductive Endocrinology & Infertility (IVF/Fertility)
SECONDARYHLAAALAJ
Prenatal, Newborn & Reproductive Diagnostics (NIPT, IVF/PGT, newborn screening)
NAICS code1 code
  • Family Planning Centers621410
SIC code1 code
  • Services-Specialty Outpatient Facilities, Nec8093
Product category
Fertility Services
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Fertility Treatment Services
TypeOne Time License
Description

Nova IVF generates revenue through providing fertility treatments including IVF, ICSI, IUI, PGT, and related procedures. Services are offered at per-cycle pricing with additional costs for supplementary procedures, medications, and diagnostics. Treatment costs vary by procedure type and location, with financing options including EMI available to patients.

novaivffertility.com
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure
Pricing details9 tiers
1IUI Treatment - Coimbatore
ModelUnit PricingBilling cadencePay-as-you-go
Notes

IUI cycle starts from ₹7,500

novaivffertility.com
2IVF Treatment - Coimbatore
ModelUnit PricingBilling cadencePay-as-you-go
Notes

IVF treatment starts from ₹99,000

novaivffertility.com
3ICSI Treatment - Coimbatore
ModelUnit PricingBilling cadencePay-as-you-go
Notes

ICSI starts from ₹2,25,000 (for medium dosage of injection). Embryo Freezing costs around ₹20,000, Embryo Thawing about ₹24,200.

novaivffertility.com
4PGT - Coimbatore
ModelUnit PricingBilling cadencePay-as-you-go
Notes

PGT ranges from ₹80,000 to ₹1,50,000 depending on type (PGT-A, PGT-M, or PGT-SR) and number of embryos tested.

novaivffertility.com
5IUI Treatment - Chennai
ModelUnit PricingBilling cadencePay-as-you-go
Notes

IUI starts at Rs. 9,000 per cycle

novaivffertility.com
6IVF Treatment - Chennai
ModelUnit PricingBilling cadencePay-as-you-go
Notes

IVF starts from Rs. 1,20,000

novaivffertility.com
7ICSI Treatment - Chennai
ModelUnit PricingBilling cadencePay-as-you-go
Notes

ICSI ranges from Rs. 1,20,000 to Rs. 2,30,000 per cycle

novaivffertility.com
8PGT - Chennai
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Preimplantation genetic diagnosis per embryo is typically Rs. 17,000, cost increases with number of embryos tested

novaivffertility.com
9Fertility Test Package
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Exclusive Rs.999/- Package for initial fertility testing

novaivffertility.com
GTM typeB2C
B2C
Offering typeServices
Services
Brand1 of 3 records shown
1Self-cycle™ IVF
Description

Nova's proprietary IVF approach that uses the couple's own eggs and sperm to achieve biological parenthood, emphasizing the encouraged choice for couples seeking fertility treatment.

novaivffertility.com
+2 more records
Core offering1 text field

Nova IVF Fertility is a fertility services chain that delivers assisted reproductive technology (ART) treatments including IVF, ICSI, IUI, PGT, vitrification, donor programs, and advanced procedures such as ERA, Ovarian PRP, LIT, TESA, and PESA across a network of 120 clinics in 75 Indian cities. It also serves international patients from SAARC countries (Bangladesh and Sri Lanka) and runs an embryology training academy.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 81% IVF success rates
+3 more records
Product overview1 text field

Nova IVF Fertility operates as a comprehensive fertility services chain offering a unified platform of treatment services across 120 centres in 75 cities across India. The portfolio centres around Self-cycle™ IVF as the core preferred approach, supported by advanced technologies including RFID electronic witnessing for process safety and AI-powered embryo selection (Vita Embryo). The service offering spans the full fertility journey from assessment through treatment, encompassing core ART services (IUI, IVF, ICSI), advanced diagnostics (PGT, ERA), preservation services (vitrification for egg/embryo/sperm), donor programs, and specialised treatments (LIT, Ovarian PRP, fertility surgeries). The network follows standardised international protocols developed in collaboration with leading global IVF chains, supported by in-house embryology labs and counselling services.

Product and service11 records
1IVF Treatment
CategoryCore treatment service
Description

In-vitro fertilisation procedure involving egg retrieval, laboratory fertilisation with partner's sperm, and embryo transfer to the uterus for couples and individuals seeking to conceive.

2ICSI Treatment
CategoryCore treatment service
Description

Intracytoplasmic Sperm Injection procedure involving direct injection of sperm into an egg, typically used for couples with male-factor infertility as part of the IVF process.

3IUI Treatment
CategoryCore treatment service
Description

Intrauterine Insemination procedure involving insertion of prepared sperm directly into the uterus to increase fertilisation chances for couples with select fertility issues.

4Preimplantation Genetic Testing (PGT)
CategoryAdvanced diagnostic service
Description

Screening test performed on embryos before IVF transfer to identify chromosomal abnormalities or genetic disorders, including PGT-A (aneuploidy), PGT-M (monogenic), and PGT-SR (structural rearrangements).

5Vitrification (Egg, Embryo, Sperm Freezing)
CategoryPreservation service
Description

Ultra-rapid freezing technology for preserving eggs, embryos, and sperm with high survival rates for future fertility treatments, including fertility preservation for cancer patients.

6Self-cycle IVF
CategoryCore treatment service
Description

Nova IVF's signature fertility treatment approach that enables couples and single individuals to achieve biological parenthood using their own eggs and sperm, following international protocols and described as the most encouraged choice at Nova IVF.

7Advanced IVF Solutions
CategoryAdvanced treatment service
Description

Specialised protocols and advanced techniques for complex fertility cases including recurrent implantation failure and poor responders.

8Embryology Services
CategoryLaboratory service
Description

Expert laboratory culture, monitoring, and selection of highest-quality embryos for transfer or freezing, including time-lapse technology monitoring and blastocyst culture.

9Infertility Counselling
CategorySupport service
Description

Psychological support and counselling services for patients undergoing fertility treatment, addressing emotional challenges throughout the journey.

10Donation Program (Embryo/Egg/Sperm)
CategoryDonor service
Description

Donation program connecting patients with screened egg, embryo, and sperm donors to help build families.

11Andrology Treatment
Scale indicator13 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-03-10
Description

Nova IVF acquired a majority stake in Kerala-based CRAFT Hospitals for approximately $40 million (₹368 crore). CRAFT is an established fertility clinic with over 55,000 babies born and 30+ years of history. The acquisition marks Nova's entry into Kerala with plans for 10 new centers over 3-5 years.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Nova IVF Fertility is a unit of Rhea Healthcare Pvt Ltd, which operates the fertility chain under the Nova IVF brand.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
1Bloom Fertility Center
TypeDirect peer
Description

India-based fertility chain providing comprehensive IVF and reproductive medicine services at multiple centers, targeting similar middle-to-upper income patient segments as Nova IVF.

TypeDirect peer
Description

India's largest fertility chain and Nova IVF's most direct competitor, operating 150+ centers across India with similar IVF, ICSI, and ART service offerings targeted at the same patient base.

TypeDirect peer
Description

Fertility arm of Cloudnine Group, operating multiple IVF centers across major Indian cities with comparable ART services, embryology labs, and premium brand positioning targeting urban fertility patients.

TypeDirect peer
Description

Multi-country fertility chain with significant India presence offering IVF, ICSI, PGT, and andrology services through advanced embryology labs, directly competing with Nova in tier-1 cities.

TypeDirect peer
Description

South India-based fertility chain operating multiple IVF centers with comparable treatment portfolio (IVF, ICSI, IUI, donor programs) and serves overlapping patient base, particularly in Andhra Pradesh and Telangana.

6Milann
TypeDirect peer
Description

Indian fertility chain (formerly Bangalore Integrated Fertility Centre) operating multiple centers offering IVF, ICSI, and advanced reproductive treatments, headquartered in Nova's home market of Bangalore.

TypeBroad incumbent
Description

Fertility arm of Apollo Hospitals, one of India's largest hospital chains. Offers IVF services across multiple cities as part of broader healthcare portfolio, leveraging the Apollo brand and patient referrals.

TypeEmerging player
Description

Indian fertility chain associated with the Motherhood hospital brand, operating a smaller but growing network of fertility centers with comparable IVF and ART service offerings.

9Manipal Fertility
TypeBroad incumbent
Description

Fertility services arm of Manipal Hospitals group providing IVF treatment across South and West India. Leverages a large hospital network for referrals and offers similar ART procedures as Nova.

10Center for Reproductive Medicine (CRAFT) — pre-acquisition standalone peer reference
TypeRegional player
Description

Kerala-based fertility provider now majority-owned by Nova IVF; prior to acquisition it was a regional fertility chain serving South Indian patients. It remains a comparable regional peer archetype in Kerala's fertility market.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI capability4 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature11 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A2 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Nova IVF Fertility

Fertility Servicesnovaivffertility.com

Nova IVF Fertility is an India-based fertility services chain operating 120 clinics across 75 cities, providing IVF, ICSI, IUI, PGT, and fertility preservation to couples and individuals, including SAARC international patients, under parent Asia Healthcare Holdings (TPG Capital).

What Nova IVF Fertility does

Nova IVF Fertility operates one of India's largest assisted reproductive technology (ART) clinic networks, with 120 centers across 75 cities serving couples and individuals seeking fertility treatment, including patients from SAARC countries such as Bangladesh and Sri Lanka. The company's service portfolio spans the full fertility journey, from initial assessment through advanced procedures, including IUI, IVF, ICSI, PGT, vitrification, donor programs, fertility-preservation services, and specialised treatments such as Ovarian PRP and Lymphocyte Immunisation Therapy. Its core proprietary approach is Self-cycle™ IVF, which prioritises use of the couple's own gametes, supported by in-house developed clinical technology including an RFID-based electronic witnessing system that prevents sample mix-ups, time-lapse embryo monitoring, MACS and ZyMot sperm selection, PICSI, Embryo Glue, and Endometrial Receptivity Analysis.

The technology stack was extended in August 2025 with the launch of Vita Embryo, an AI-enabled computer-vision platform for embryo selection, designed to improve IVF success rates. Nova IVF generates revenue through per-cycle unit pricing on fertility procedures (IUI at ~₹7,500-9,000, IVF from ₹99,000-120,000, ICSI at ₹120,000-225,000, PGT at ₹80,000-150,000), with EMI financing offered to patients and a transparent pricing policy. The business is run as a unit of Rhea Healthcare Pvt Ltd, under Asia Healthcare Holdings, which is backed by global private equity firm TPG Capital; New Enterprise Associates was an early institutional investor in 2010. Nova IVF follows a direct-to-consumer go-to-market supported by a multi-channel digital presence (website, SEO, social media, WhatsApp, phone) and operates ancillary talent and training assets including the Nova Embryology Academy (NACET) and fellowship programs in Reproductive Medicine and Embryology.

Nova IVF Fertility firmographics

Firmographics
Name
Nova IVF Fertility
Legal name
Nova IVF Fertility (A unit of Rhea Healthcare Pvt Ltd)
Website
https://novaivffertility.com
Company type
Private
Founded year
2006
Operating status
Operating
Headcount range
1,001–5,000 employees
Short description
Nova IVF Fertility is an India-based fertility services chain operating 120 clinics across 75 cities, providing IVF, ICSI, IUI, PGT, and fertility preservation to couples and individuals, including SAARC international patients, under parent Asia Healthcare Holdings (TPG Capital).
Ownership category
akta.pro rank

Nova IVF Fertility industry classification

Industry
Product category
Fertility Services
NAICS
Family Planning Centers (621410)
SIC
Services-Specialty Outpatient Facilities, Nec (8093)
akta.pro industry
PRIMARYHLAFAJAD
Fertility, Reproductive Endocrinology & IVF Centers
Healthcare & Life Sciences/Healthcare Providers & Systems/Women’s & Children’s Health Providers
SECONDARYHLAKAJAC
Reproductive Endocrinology & Infertility (IVF/Fertility)
SECONDARYHLAAALAJ
Prenatal, Newborn & Reproductive Diagnostics (NIPT, IVF/PGT, newborn screening)

Keywords

  • IVF treatment
  • Fertility services
  • Assisted reproduction
  • Fertility preservation
  • Embryology services

Where Nova IVF Fertility is headquartered

Location

Headquarters

HQ city
Bangalore
HQ country
India
HQ region
Asia

Offices30 records

Markets served

Nova IVF Fertility business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

  1. Fertility Treatment Services: Nova IVF generates revenue through providing fertility treatments including IVF, ICSI, IUI, PGT, and related procedures. Services are offered at per-cycle pricing with additional costs for supplementary procedures, medications, and diagnostics. Treatment costs vary by procedure type and location, with financing options including EMI available to patients.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goIUI Treatment - Coimbatore
Unit PricingPay-as-you-goIVF Treatment - Coimbatore
Unit PricingPay-as-you-goICSI Treatment - Coimbatore
Unit PricingPay-as-you-goPGT - Coimbatore
Unit PricingPay-as-you-goIUI Treatment - Chennai
Unit PricingPay-as-you-goIVF Treatment - Chennai
Unit PricingPay-as-you-goICSI Treatment - Chennai
Unit PricingPay-as-you-goPGT - Chennai
Unit PricingPay-as-you-goFertility Test Package

Go-to-market motion1 record

Distribution channels4 records

Marketing channels8 records

Nova IVF Fertility product offering

Product offering

Core offering

Nova IVF Fertility is a fertility services chain that delivers assisted reproductive technology (ART) treatments including IVF, ICSI, IUI, PGT, vitrification, donor programs, and advanced procedures such as ERA, Ovarian PRP, LIT, TESA, and PESA across a network of 120 clinics in 75 Indian cities. It also serves international patients from SAARC countries (Bangladesh and Sri Lanka) and runs an embryology training academy.

Product overview

Nova IVF Fertility operates as a comprehensive fertility services chain offering a unified platform of treatment services across 120 centres in 75 cities across India. The portfolio centres around Self-cycle™ IVF as the core preferred approach, supported by advanced technologies including RFID electronic witnessing for process safety and AI-powered embryo selection (Vita Embryo). The service offering spans the full fertility journey from assessment through treatment, encompassing core ART services (IUI, IVF, ICSI), advanced diagnostics (PGT, ERA), preservation services (vitrification for egg/embryo/sperm), donor programs, and specialised treatments (LIT, Ovarian PRP, fertility surgeries). The network follows standardised international protocols developed in collaboration with leading global IVF chains, supported by in-house embryology labs and counselling services.

Differentiator

Problem solved

Functional benefit

Brands

  • Self-cycle™ IVF: Nova's proprietary IVF approach that uses the couple's own eggs and sperm to achieve biological parenthood, emphasizing the encouraged choice for couples seeking fertility treatment.
  • Vita Embryo
  • Nova Embryology Academy (NACET)

Products and services

  • IVF Treatment In-vitro fertilisation procedure involving egg retrieval, laboratory fertilisation with partner's sperm, and embryo transfer to the uterus for couples and individuals seeking to conceive.
  • ICSI Treatment Intracytoplasmic Sperm Injection procedure involving direct injection of sperm into an egg, typically used for couples with male-factor infertility as part of the IVF process.
  • IUI Treatment Intrauterine Insemination procedure involving insertion of prepared sperm directly into the uterus to increase fertilisation chances for couples with select fertility issues.
  • Preimplantation Genetic Testing (PGT) Screening test performed on embryos before IVF transfer to identify chromosomal abnormalities or genetic disorders, including PGT-A (aneuploidy), PGT-M (monogenic), and PGT-SR (structural rearrangements).
  • Vitrification (Egg, Embryo, Sperm Freezing) Ultra-rapid freezing technology for preserving eggs, embryos, and sperm with high survival rates for future fertility treatments, including fertility preservation for cancer patients.
  • Self-cycle IVF Nova IVF's signature fertility treatment approach that enables couples and single individuals to achieve biological parenthood using their own eggs and sperm, following international protocols and described as the most encouraged choice at Nova IVF.
  • Advanced IVF Solutions Specialised protocols and advanced techniques for complex fertility cases including recurrent implantation failure and poor responders.
  • Embryology Services Expert laboratory culture, monitoring, and selection of highest-quality embryos for transfer or freezing, including time-lapse technology monitoring and blastocyst culture.
  • Infertility Counselling Psychological support and counselling services for patients undergoing fertility treatment, addressing emotional challenges throughout the journey.
  • Donation Program (Embryo/Egg/Sperm) Donation program connecting patients with screened egg, embryo, and sperm donors to help build families.
  • Andrology Treatment

Quantifiable outcome

  • 81% IVF success rates
  • +3 more outcomes

Companies that use Nova IVF Fertility

Customer profile

Named customers1 record

Segments3 records

Ideal customer profiles1 record

Nova IVF Fertility technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature11 records

Nova IVF Fertility partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core and minor.

  • CRAFT Hospitals and Research CentrecoreStrategic or Co-development Partner · 10 March 2026Nova IVF acquired a majority stake in Kerala-based CRAFT Hospitals for approximately $40 million (₹368 crore). CRAFT is an established fertility clinic with over 55,000 babies born and 30+ years of history. The acquisition marks Nova's entry into Kerala with plans for 10 new centers over 3-5 years.
  • Rhea Healthcare Pvt LtdminorStrategic or Co-development PartnerNova IVF Fertility is a unit of Rhea Healthcare Pvt Ltd, which operates the fertility chain under the Nova IVF brand.

Scale indicators13 records

Recent moves7 records

Expansion highlights5 records

Nova IVF Fertility competitors and assessment

Company assessment

Direct peers

  • Bloom Fertility Center: India-based fertility chain providing comprehensive IVF and reproductive medicine services at multiple centers, targeting similar middle-to-upper income patient segments as Nova IVF.
  • Indira IVF: India's largest fertility chain and Nova IVF's most direct competitor, operating 150+ centers across India with similar IVF, ICSI, and ART service offerings targeted at the same patient base.
  • Cloudnine Fertility: Fertility arm of Cloudnine Group, operating multiple IVF centers across major Indian cities with comparable ART services, embryology labs, and premium brand positioning targeting urban fertility patients.
  • ART Fertility Clinics: Multi-country fertility chain with significant India presence offering IVF, ICSI, PGT, and andrology services through advanced embryology labs, directly competing with Nova in tier-1 cities.
  • Oasis Fertility: South India-based fertility chain operating multiple IVF centers with comparable treatment portfolio (IVF, ICSI, IUI, donor programs) and serves overlapping patient base, particularly in Andhra Pradesh and Telangana.
  • Milann: Indian fertility chain (formerly Bangalore Integrated Fertility Centre) operating multiple centers offering IVF, ICSI, and advanced reproductive treatments, headquartered in Nova's home market of Bangalore.

Broad incumbents

  • Apollo Fertility: Fertility arm of Apollo Hospitals, one of India's largest hospital chains. Offers IVF services across multiple cities as part of broader healthcare portfolio, leveraging the Apollo brand and patient referrals.
  • Manipal Fertility: Fertility services arm of Manipal Hospitals group providing IVF treatment across South and West India. Leverages a large hospital network for referrals and offers similar ART procedures as Nova.

Emerging players

  • Motherhood Fertility: Indian fertility chain associated with the Motherhood hospital brand, operating a smaller but growing network of fertility centers with comparable IVF and ART service offerings.

Regional players

  • Center for Reproductive Medicine (CRAFT) — pre-acquisition standalone peer reference: Kerala-based fertility provider now majority-owned by Nova IVF; prior to acquisition it was a regional fertility chain serving South Indian patients. It remains a comparable regional peer archetype in Kerala's fertility market.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Nova IVF Fertility social profiles

Digital presence

Nova IVF Fertility financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Nova IVF Fertility leadership team

Management profile

Number of profiles

Profiles1 record

Nova IVF Fertility subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Nova IVF Fertility funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Nova IVF Fertility M&A and investment

M&A and investment

M&A2 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Nova IVF Fertility

What does Nova IVF Fertility do?

Nova IVF Fertility is a fertility services chain that delivers assisted reproductive technology (ART) treatments including IVF, ICSI, IUI, PGT, vitrification, donor programs, and advanced procedures such as ERA, Ovarian PRP, LIT, TESA, and PESA across a network of 120 clinics in 75 Indian cities. It also serves international patients from SAARC countries (Bangladesh and Sri Lanka) and runs an embryology training academy.

Is Nova IVF Fertility a public or private company?

Nova IVF Fertility is a private company. It is classified as private equity controlled and is currently operating.

When was Nova IVF Fertility founded?

Nova IVF Fertility was founded in 2006. It employs 1,001 to 5,000 people.

Where is Nova IVF Fertility based?

Nova IVF Fertility is headquartered in Bangalore, India, in the Asia region.

How does Nova IVF Fertility make money?

One revenue line is on record: fertility Treatment Services.

Who are Nova IVF Fertility's main competitors?

Direct peers on record are Bloom Fertility Center, Indira IVF, Cloudnine Fertility, ART Fertility Clinics, Oasis Fertility and Milann. Broad incumbents are Apollo Fertility and Manipal Fertility. Motherhood Fertility is listed as an emerging player. Center for Reproductive Medicine (CRAFT) — pre-acquisition standalone peer reference is listed as a regional player.

Does Nova IVF Fertility have an API?

No public API is recorded for Nova IVF Fertility.

What industry is Nova IVF Fertility in?

Nova IVF Fertility's product category is Fertility Services. Its primary akta.pro industry code is HLAFAJAD, Fertility, Reproductive Endocrinology & IVF Centers, with a secondary code of HLAKAJAC, Reproductive Endocrinology & Infertility (IVF/Fertility). Its NAICS code is 621410 and its SIC code is 8093.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
The TribunePCOS detected in 14.4% women seeking fertility treatment: Jalandhar doctorA study led by Dr Jasmine Dahiya at Nova IVF Fertility Centre in Jalandhar found PCOS in 14.4% of women seeking fertility treatment. The highest prevalence was 29.4% among women aged 21–25, compared to 5.3% in those aged 36–40. The team called for further research on PCOS and metabolic health.www.passionateinmarketing.comMysuru Couple Welcomes Baby After Advanced IVF TreatmentA couple in Mysuru, Karnataka successfully welcomed a healthy baby following advanced IVF treatment at Nova IVF Fertility after the male partner was diagnosed with severe azoospermia and bilateral varicocele. Using advanced sperm retrieval technique TESA (Testicular Sperm Aspiration) combined with ICSI (Intracytoplasmic Sperm Injection), the couple achieved pregnancy on their first attempt. The clinic highlights this case as an example of how personalised treatment planning can help couples overcome complex infertility cases and achieve biological parenthood.The Times of IndiaAfter 8 years of infertility and 3 failed IVF cycles, Bengaluru couple welcomes first baby after doctors uncover hidden cause that donor treatment would have missed - The Times of IndiaA Bengaluru couple (Ananya, 35 and Aswin, 36) welcomed their first child after eight years of infertility and three failed IVF cycles at another clinic, where they had been advised to pursue donor treatment. Fertility specialists at Nova IVF Fertility identified the root cause as fallopian tube issues and sperm DNA damage, enabling a successful pregnancy using the couple's own embryos with advanced techniques including PICSI, microfluidics for sperm selection, PGT-A testing, and endometrial receptivity assay to determine the optimal transfer window. The case highlights the importance of personalized evaluation in failed IVF cycles, as at least 40% of couples seeking treatment at the clinic had experienced previous IVF failures with underlying causes beyond embryo quality.TheHealthSiteCan 'clean eating' harm hormones? Doctor warns restrictive wellness trends may quietly disrupt women’s healthDr. Hima Deepthi, Clinical Director and Fertility Specialist at Nova IVF Fertility in Hyderabad, has warned that overly restrictive "clean eating" trends may be quietly disrupting women's hormonal health, fertility, and menstrual cycles despite appearing healthy on social media. Research indicates that chronic under-eating, extreme dietary restrictions, excessive fasting, and other restrictive eating patterns can interfere with hormonal pathways, leading to symptoms such as irregular periods, thyroid dysfunction, fatigue, mood shifts, and fertility problems. Experts note that women are particularly vulnerable to these trends, which often ignore the biological realities of women's physiology, and warn that the rise of visually curated wellness culture on platforms like Instagram and TikTok has contributed to unrealistic dietary expectations.BusinessLineNova IVF Fertility enters Kerala with Craft Fertility acquisition, 10 new centres planned over 3-5 yrsNova IVF Fertility, backed by Asia Healthcare Holdings (AHH), has acquired Craft Fertility, marking its entry into the Kerala market with plans to launch 10 new IVF centres across the state over the next three to five years. The acquisition provides Nova access to Craft's four decades of clinical expertise in reproductive medicine while addressing Kerala's declining fertility rate of approximately 1.35–1.7 children per woman, well below the replacement level of 2.1. Nova IVF Fertility currently operates a pan-India network performing over 19,000–21,000 IVF treatments annually across more than 150 fertility specialists and 200 embryologists.Fortune IndiaNova IVF Fertility acquires Kerala's Craft Fertility; to open 10 new centres in the stateNova IVF Fertility, owned by Asia Healthcare Holdings, has acquired Craft Fertility, a Kerala-based fertility clinic with over three decades of history and more than 55,000 successful births, for an undisclosed amount. The acquisition will facilitate the opening of 10 new fertility centers across Kerala over the next 3–5 years, expanding access to reproductive medicine in the state. The deal grants Nova IVF access to Craft Fertility's four decades of clinical practices in reproductive medicine under the leadership of Dr. C. Mohamed Ashraf.Angel OneNova IVF Acquires Majority Stake in Kerala’s CRAFT Hospitals in Deal Valued at About $40 MillionNova IVF Fertility has acquired a majority stake in CRAFT Hospitals and Research Centre, a Kerala-based fertility care provider, in a transaction valuing the company at approximately $40 million (around ₹368 crore). The acquisition marks Nova IVF's entry into Kerala, expanding its footprint in South India's specialized healthcare market beyond its existing single centre in Palakkad. The deal comes amid growing private equity interest in Kerala's healthcare sector, which has attracted over $700 million in investments over the past two years.The Times of IndiaNova IVF picks up majority stake in Kerala’s CRAFT Hospitals at $40-mn valuationNova IVF Fertility has acquired a majority stake in CRAFT Hospitals, one of Kerala's leading fertility centres, in a deal valuing the company at approximately $40 million (around ₹368 crore). The acquisition addresses Nova's gap in Kerala, where it currently operates only one centre in Palakkad, marking the fertility chain's formal entry into the state. The transaction strengthens Nova's footprint across South India while building on CRAFT's established clinical legacy in fertility services.WhalesbookNova IVF Buys CRAFT Hospitals for $40M to Boost Kerala PresenceBengaluru-based Nova IVF Fertility has acquired a majority stake in Kerala-based CRAFT Hospitals for approximately $40 million (₹368 crore), significantly expanding its presence in South India and gaining immediate access to Kerala's specialized healthcare market. The deal was facilitated by investment bank Advay Capital for CRAFT and its promoter, and Nova IVF operates under Asia Healthcare Holdings, which is backed by global private equity firm TPG Capital. India's fertility services market is projected to grow from $1.5 billion in 2024 to over $4.4 billion by 2033, and the transaction reflects ongoing consolidation in this rapidly expanding sector, though Nova IVF faces integration challenges and high competitive intensity.EIN PresswirePrimary Ovarian Insufficiency Market 2026: Explore Emerging Treatments Addressing Unmet Women’s Health NeedsThe Business Research Company has published a market report on the Primary Ovarian Insufficiency market, projecting it will grow from $1.18 billion in 2025 to $1.3 billion in 2026 at a compound annual growth rate of 10.0%. The report identifies Mayo Clinic and Johns Hopkins Medicine as leading market players with 4% market share each in 2024, with the top 10 players accounting for 21% of total market revenue. Key competitive trends include the advancement of AI-enabled embryo selection platforms, such as Nova IVF Fertility's Vita Embryo technology launched in August 2025, and companies are focusing on hormone replacement therapies, fertility-preservation solutions, and integrated fertility-endocrinology care platforms.